Corbus Pharmaceuticals Holdings, Inc. (LON:0SZI)
London flag London · Delayed Price · Currency is GBP · Price in USD
7.35
-0.09 (-1.21%)
Feb 12, 2026, 4:54 PM GMT

LON:0SZI Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
10711521115777
Market Cap Growth
13.00%447.26%82.57%-79.82%-25.99%-71.14%
Enterprise Value
32-1016-22-336
Last Close Price
5.679.274.872.6414.4227.69
PS Ratio
----87.4526.68
PB Ratio
1.551.01-3.870.421.122.32
P/TBV Ratio
1.551.01-0.421.122.32
EV/Sales Ratio
-----12.54
Debt / Equity Ratio
0.020.02-3.020.760.390.59
Asset Turnover
----0.010.05
Quick Ratio
6.1012.610.664.685.742.76
Current Ratio
6.3112.940.744.765.892.89
Return on Equity (ROE)
-55.65%-59.34%-341.99%-82.95%-79.80%-432.68%
Return on Assets (ROA)
-34.69%-33.07%-59.57%-25.02%-33.32%-101.37%
Return on Capital Employed (ROCE)
-82.10%-33.80%1244.60%-64.90%-61.70%-174.50%
Earnings Yield
-47.16%-27.98%-166.94%-305.90%-59.19%-105.92%
FCF Yield
--29.08%-135.11%-271.30%-62.56%-95.36%
Buyback Yield / Dilution
-36.33%-152.23%-3.76%-1.85%-57.23%-22.28%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.